2019 annual financial data
Cartesian Therapeutics 2019 Operating margin
Cartesian Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -785.61%.
Operating income was -52,455,000 USD and net income was -55,350,000 USD.
Operating cash flow was -51,435,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,677,000 USD
- Operating income
- -52,455,000 USD
- Net income
- -55,350,000 USD
- Operating cash flow
- -51,435,000 USD